EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in non‐germ cell tumours of the testis: focus on new molecular developments in sex cord‐stromal tumours

João Lobo iD, Andres M Acosta iD

Histopathology · 2026

DOI: 10.1111/his.70006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Histopathology, 2026. Verfasst von João Lobo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), R. Dr. António B…. Hauptthemen laut MEDLINE: Sex Cord-Gonadal Stromal Tumors, Testicular Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testicular sex cord‐stromal tumours (TSCSTs) represent ~4%–8% of all testicular neoplasms. Most show a Leydig or Sertoli cell phenotype and exhibit benign clinical behaviour. However, a subset of ~10% is malignant and clinically problematic, as TGCTs do not respond to systemic therapy. Classification of TSCSTs has relied on morphology, with several entities being defined based on their resemblance to more common ovarian counterparts (e.g. granulosa cell tumours). In recent years, multiple clinicopathologic and molecular studies have improved our understanding of the mechanisms that underlie pathogenesis and progression in TSCSTs, providing data that can be useful to refine classification and prognostication. In this review, we summarise the major recent advances in TSCSTs, focusing on molecular alterations and biomarkers relevant for diagnosis, classification and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sex Cord-Gonadal Stromal TumorsTesticular NeoplasmsHumansMaleBiomarkers, TumorPrognosis

Stichwörter der Autor:innen

Leydig cell tumourSertoli cell tumourgranulosa cell tumoursex cord stromal tumourstesticular cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), R. Dr. António Bernardino de Almeida, Porto, Portugal.
  • Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), R. Dr. António Bernardino de Al…
  • Department of Pathology and Molecular Immunology, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
  • Department of Pathology, Indiana University, Indianapolis, Indiana, USA.

ORCID-Profile: João Lobo, Andres M Acosta

Zitieren

APA

Lobo, J., & Acosta, A. M. (2026). Advances in non‐germ cell tumours of the testis: focus on new molecular developments in sex cord‐stromal tumours. Histopathology. https://doi.org/10.1111/his.70006

Vancouver

Lobo J, Acosta AM. Advances in non‐germ cell tumours of the testis: focus on new molecular developments in sex cord‐stromal tumours. Histopathology. 2026. doi:10.1111/his.70006

BibTeX
@article{Lobo2026,
  author = {Lobo, João and Acosta, Andres M},
  title = {Advances in non‐germ cell tumours of the testis: focus on new molecular developments in sex cord‐stromal tumours},
  journal = {Histopathology},
  year = {2026},
  doi = {10.1111/his.70006}
}
Kostenlos starten →